Regeneron says antibody ‘cocktail’ helps COVID-19 patients recover quickly

An experimental antibody “cocktail” developed by biotech firm Regeneron appears to help coronavirus patients recover more quickly. The company on Tuesday released early data from a clinical trial showing the drug helped people infected with COVID-19 shake their symptoms faster and reduced the amount of the virus in their bodies. People who had not mounted…